Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Release delayed solid oral prophylactic or pregnancy stopping pill and its use

A technology for terminating pregnancy and contraceptives, which can be used in medical preparations containing active ingredients, drug delivery, drug combinations, etc., and can solve the problems of drug treatment effect, low dose and adverse reactions.

Inactive Publication Date: 2009-09-16
REGENEX PHARMA LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] 2) Due to various reasons, the patient did not take the same dose of the drug according to the instructions or the doctor's advice, resulting in the actual dose of the drug being lower than the required dose, which may affect the final therapeutic effect of the drug
[0016] It can be seen that vomiting caused by taking solid oral contraceptives or pregnancy termination drugs will lead to inaccurate dosage of the drugs taken, and thus may affect the preventive or therapeutic effect of the drugs
Additional drugs to prevent vomiting can lead to other more adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Fully mix 0.75g or 1.50g of levonorgestrel with 80g of lactose, 5g of polyvinylpyrrolidone, 10g of sodium carboxymethylcellulose, 20g of starch, and 50g of microcrystalline cellulose and other powdery excipients, granulate with water, After drying and granulating, press into 1000 round tablets with a diameter of 8 mm, and the content of levonorgestrel in each tablet is 0.75 mg or 1.50 mg. At the same time, use 88% ethanol as a solvent, prepare the special coating material containing cellulose acetate phthalate into a suspension of 10-15% solids, mix well, and coat the tablet with multiple layers . The prepared coated tablet was stirred in 750 ml of 0.1N hydrochloric acid (pH 1) for 2 hours without any disintegration or dissolution of not more than 10%. In 0.2N sodium phosphate solution (adjust the pH value to 6.8 with 1N HCl / NaOH; add 5g of sodium lauryl sulfate), the prepared coated tablet is stirred with it, and disintegration occurs in about 10 minutes , After 1 ho...

Embodiment 2

[0032] Use the prepared acrylic resin solution to spray a layer of the resin on the No. 3 capsule; or directly purchase the enteric-coated No. 3 capsule that has been approved by the state. Fully mix 10g of mifepristone with 70g of lactose, 10g of polyvinylpyrrolidone, 8g of sodium carboxymethyl cellulose, and 2g of magnesium stearate and other powdery excipients, granulate with water, dry the whole granules, and then fill them. In 1000 above-mentioned coated No. 3 capsules, the content of mifepristone in each capsule is 10 mg. The prepared coated capsules were stirred in 750 ml of 0.1N hydrochloric acid (pH 1) for 2 hours without any rupture or deformation. In a 0.2N sodium phosphate solution with a pH of 6.8, the prepared coated capsules were stirred and ruptured in about 15 minutes, and the contents of the drug capsules were thoroughly released in about 30 minutes, and the dissolution rate was measured by sampling after 1 hour. Or equal to 78%.

Embodiment 3

[0034] Dissolve 70 g of carboxymethylcellulose in boiling water, cool to room temperature, add 25 g of mifepristone to make a suspension aqueous solution, then slowly add aluminum sulfate aqueous solution and stir at a constant speed until a saturated coacervate is formed, filter and wash with water The soluble matter was removed, and then dried to form microspherical particles with an average particle diameter of 0.4mm. After the microspheres were coated with cellulose acetate phthalate, they were poured into 1000 No. 3 ordinary capsules. The content of mifepristone in each capsule was 25 mg, and the amount of mifepristone in every gram of microsphere particles The content is 250mg. The prepared capsule was stirred in 750ml of 0.1N hydrochloric acid (pH is 1) when the capsule dissolved and released the microsphere particles for 15 minutes, and continued to stir until 2 hours, all the particles were completely released from the capsule, but the microsphere particles No ruptur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a dosage form of a contraceptive and its application, in particular to a dosage form for delaying the dissolution of a solid oral contraceptive or a drug for terminating pregnancy and its application. The dosage form of delaying solid oral contraceptive or termination of pregnancy drug dissolution of the present invention is to coat one or more layers of coating on the outer layer of solid oral contraceptive or termination of pregnancy preparation or directly use delayed dissolving capsules, so that the dosage form can be It does not dissolve in an acidic medium, but dissolves in a medium with an acidity close to neutral, so that the drug will start to dissolve and absorb after it completely enters the intestine. Inaccurate dosage.

Description

technical field [0001] The invention relates to a dosage form of a contraceptive, especially a dosage form for delaying the dissolution of a solid oral contraceptive or a drug for terminating pregnancy; the invention also relates to an application of the dosage form for delaying the dissolution of a solid oral contraceptive or a drug for terminating pregnancy. Background technique [0002] There are two main types of contraceptives (excluding external contraceptives) widely used for women at present. One is derivatives of estrogen or its active or partially active mimics, such as ethinyl estradiol, ethinyl estradiol, estradiol, omexifen, etc.; the other is progesterone or its derivatives or their active or active Some active mimics, such as norethindrone, levonorgestrel, megestrol acetate, medroxyprogesterone acetate, desogestrel (Desogestrel), gestodene (Gestodene), mifepristone, 3-Keto-desogestrel, Norgestimate, Dienogest, Nomegestrol, Drospirenone Trimegestrone, etc. I...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/57A61K9/34A61K9/56A61K9/14A61P15/18A61K9/36
Inventor 卢智俊
Owner REGENEX PHARMA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com